DA-EPOCH-R for post-transplant lymphoproliferative disorders.

Christin B DeStefanoVera MalkovskaHind RafeiAarthi ShenoyKelly FitzpatrickAnita AggarwalJoseph P Catlett

Published in: European journal of haematology (2017)

Our findings support several observations in the literature that DA-EPOCH-R is efficacious and well-tolerated for the treatment of advanced, monomorphic PTLD.

Keyphrases

systematic review
epstein barr virus
combination therapy